Skip to main navigation Skip to search Skip to main content

Net Clinical Benefit of Prehospital Glycoprotein IIb/IIIa Inhibitors in Patients with ST-Elevation Myocardial Infarction and High Risk of Bleeding: Effect of Tirofiban in Patients at High Risk of Bleeding Using CRUSADE Bleeding Score.

Translated title of the contribution: Net Clinical Benefit of Prehospital Glycoprotein IIb/IIIa Inhibitors in Patients with ST-Elevation Myocardial Infarction and High Risk of Bleeding: Effect of Tirofiban in Patients at High Risk of Bleeding Using CRUSADE Bleeding Score.
  • R.S Hermanides
  • , J.P. Ottervanger
  • , J.M. ten Berg
  • , A.T. Gosselink
  • , G. Houwelingen
  • , J.H. Dambrink
  • , P.R. Stella
  • , C. Hamm
  • , A.W. van 't Hof

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionNet Clinical Benefit of Prehospital Glycoprotein IIb/IIIa Inhibitors in Patients with ST-Elevation Myocardial Infarction and High Risk of Bleeding: Effect of Tirofiban in Patients at High Risk of Bleeding Using CRUSADE Bleeding Score.
Original languageUndefined/Unknown
Pages (from-to)84-9
Number of pages6
JournalThe journal of invasive cardiology
Volume24
Issue number3
Publication statusPublished - 2012

Cite this